Stay updated on Anitocabtagene-autoleucel in MM Clinical Trial
Sign up to get notified when there's something new on the Anitocabtagene-autoleucel in MM Clinical Trial page.

Latest updates to the Anitocabtagene-autoleucel in MM Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.3.4 was added and the previous revision v3.3.3 was removed in the page history, reflecting a minor history update.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study history shows the addition of Study Design and Study Status entries on 2025-12-18 and 2025-12-17 (Revision: v3.3.3), and the deletion of the HHS Vulnerability Disclosure entry on 2025-11-13 (Revision: v3.3.2).SummaryDifference0.7%

- Check49 days agoChange DetectedThe page history shows an added site revision (v3.3.2) and the removal of the previous revision (v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe history shows an added Revision: v3.3.1 and a removed Revision: v3.2.0 in the page's version history. This is a minor site version update with no impact on the study information or primary page content.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history now shows a new Study Status entry (and a new version 12 on 2025-11-11) reflecting updated recruitment/status information, and the site-wide funding lapse notice was removed.SummaryDifference1%

- Check78 days agoChange DetectedThe Record History shows multiple version updates to the Study Status, documenting changes in recruitment status over time; the current version shows the study as Active, not recruiting.SummaryDifference0.1%

Stay in the know with updates to Anitocabtagene-autoleucel in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anitocabtagene-autoleucel in MM Clinical Trial page.